A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors

NCT05819684 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: SHR-4602 for injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.